Abstract
Background
Cryptosporidium parvum and Giardia duodenalis (assemblages A and B) are ubiquitously occurring protozoan parasites infecting a broad range of hosts. Co-infection with both parasites in suitable hosts have been reported, but information on structural or functional alterations in host cells caused by simultaneous infection is rare. Previous findings showing an enhanced replication of G. duodenalis during co-infection suggest synergistic effects of both parasites that were investigated in this in vitro study.
Methods
The tight junction proteins claudin (CLDN) 1, 4, 6, and 7 as well as the glucose transporters (GLUT) 1 and 2 of IPEC-J-2 cells were examined comparing single and co-infections on gene expression level after 24 h, 48 h, and 72 h post infection (p.i.). Additionally, an analysis of intracellular glucose levels was performed 48 h p.i.
Results
No significant changes of the gene expression of the examined tight junction proteins were observed. Regarding the glucose transporters, GLUT2 was significantly decreased in cells infected by C. parvum sporozoites compared to cells infected by G. duodenalis trophozoites 48 h p.i. (p = 0.017) as well as compared to uninfected control cells (p = 0.021). Additionally, co-infected cells showed a significantly increased intracellular glucose level (p = 0.022) and C. parvum infected cells a non-significant trend of an increased intracellular glucose level (p = 0.056) in comparison to control cells. Compared to G. duodenalis mono-infected cells, co-infected cells showed a tendency for higher intracellular glucose levels (p = 0.057).
Conclusion
Cryptosporidium parvum had an impact on GLUT2 transcript abundance and also increased glucose levels in mono- and co-infection under the tested conditions, while G. duodenalis did not alter the examined glucose transporter and tight junctions markers in this model.
Graphical Abstract
Supplementary Information
The online version contains supplementary material available at 10.1186/s13071-026-07537-4.
Keywords: Cryptosporidium parvum, Giardia duodenalis, Giardia lamblia, Giardia intestinalis, Co-infection, Glucose transport, Tight junctions
Background
Cryptosporidium parvum is an intracellular protozoan parasite causing intestinal disorders in several host species including humans. The parasite is one of the main pathogens associated with moderate to severe diarrhoea and an increased risk of mortality in toddlers from low-income countries [1–3]. The extracellular protozoan parasite Giardia duodenalis can be classified in eight assemblages, whereby the assemblages C-H are considered to be rather host specific. Parasites of the assemblages A and B occur in a wide host range and are also zoonotic [4]. The clinical outcome associated with giardiasis ranges from asymptomatic patients to patients with clinical symptoms such as abdominal pain and diarrhoea, whereby the reasons for this variation are poorly understood yet [5].
Although occupying different locations within the intestinal tract of the hosts, both parasites affect the main functions of the intestinal epithelium: shielding the organism from luminal toxins, bacteria and other harmful substances and at the same time mediating the effective vectorial transport of nutrients and electrolytes [6]. Several studies reported the modification of barrier forming tight junction proteins, e.g., claudins, in response to infection with C. parvum or G. duodenalis in different in vitro and in vivo models [7, 8]. Furthermore, it has been shown that parasites are capable of influencing host organisms on their own behalf for nutrient supply or longevity, including the glucose uptake into the host cells [9–11]. The transporters ensuring the transepithelial glucose transport across the small intestinal epithelium are the Na+/glucose cotransporter (SGLT1) and glucose transporter (GLUT) 2. While SGLT1 is located in the brush border membrane and mediates the secondary active uptake of glucose from the gut lumen, GLUT2 is generally found in the basolateral membrane and mediates the facilitated diffusion of hexoses into the bloodstream [12–14]. Additionally, GLUT1 is also able to transport monosaccharides and commonly found in the majority of mammalian cells [15]. Since C. parvum lacks many metabolic pathways, it heavily relies on glucose obtained from host cells as important carbon source [16]. In previous studies we showed an altered glucose absorption and metabolism both in an intestinal epithelial cell line and calves infected by C. parvum, manifesting in increased intracellular glucose levels, modified glucose transporter abundance and enhanced intracellular glucose metabolism [10, 17]. While the main source of energy for G. duodenalis is arginine and the parasite induces changes in the arginine metabolism of the host, Giardia can also use glucose for energy supply [18]. Further, it has been shown that G. duodenalis sonicates caused an enhanced glucose uptake via SGLT1 in Caco-2 cells in presence of high glucose media, maybe showing a potential cell rescue mechanism in response to parasite-induced cell apoptosis [19].
Co-infections with both parasites have been reported in several host species such as calves, dogs, red foxes, and raccoon dogs [20–22]. Therefore, a potentiation of both parasites’ effects on intestinal barrier function as well as glucose transport is possible and may contribute to more severe disease. Nevertheless, information on interactions between the individual pathogens or host cells in parasitic co-infections associated with cryptosporidiosis or giardiasis is rare. To examine the impact on the replication of individual parasites during simultaneous infection, we established an in vitro model in IPEC-J2 cells that we used for C. parvum infection solely before [10]. While co-infection led to a significantly increased proliferation of G. duodenalis trophozoites, no effect on the growth of C. parvum was detected [23]. Based on our findings in former studies [10, 17, 24], we used our in vitro model to investigate the potential influence of co-infections on the nutrient supply and epithelial barrier function. Therefore, we examined glucose transporters and tight junctions comparing single and co-infections with C. parvum and G. duodenalis in IPEC-J2 cells.
Methods
For all experiments, trophozoites of G. duodenalis WB6 (assemblage AI) obtained from the Robert Koch Institute (Berlin, Germany), and oocysts of an in-house isolate of C. parvum (LE-23-Cp-23, Markranstädt) were used as described by Kirchner et al. [23]. The trophozoites were maintained under anaerobic conditions in sterile filtered modified TYI-S-33 medium as stated elsewhere [23]. The infection of IPEC-J2 cells by either C. parvum sporozoites or G. duodenalis trophozoites or both parasites was realized as specified by Kirchner et al. [23]. More precisely, 2 × 105 IPEC-J2 cells were seeded in 24-well plates and grown for 72 h covered with growth medium (GM) containing Iscove’s Modified Dulbecco´s Medium (IMDM; Gibco™, ThermoFisher Scientific, Waltham, USA), supplemented with 50% Ham´s F-12 Nutrient Mixture W/ GlutaMAX™-I (F-12; Gibco™, ThermoFisher Scientific, Waltham, USA), as well as 10% foetal calf serum (FCS; PAN Biotech™, Aidenbach, Germany), and 0.002 mM L-glutamine (Gibco™, ThermoFisher Scientific, Waltham, USA). Further on, 0.5 U/mL Penicillin, 0.5 µg/mL Streptomycin (Gibco™, ThermoFisher Scientific, Waltham, USA) and 0.025 mL Amphotericin B (PAN Biotech™, Aidenbach, Germany) were added. For infection, excystation of C. parvum oocysts was performed as stated elsewhere [23], and sporozoites were resuspended in Dulbecco`s Modified Eagle Medium (DMEM; Gibco™, ThermoFisher Scientific, Waltham, USA) containing additionally 2% FCS, 0.5 U/mL Penicillin, 0.5 µg/mL Streptomycin (Gibco™, ThermoFisher Scientific, Waltham, USA), 0.025 mL Amphotericin B (PAN Biotech™, Aidenbach, Germany), 0.01 mM sodium pyruvate (ThermoFisher Scientific, Waltham, USA), as well as 0.04 mM L-glutamine (Gibco™, ThermoFisher Scientific, Waltham, USA), and added to IPEC-J2 cells washed with phosphate buffered saline three times before (PBS; Gibco™, ThermoFisher Scientific, Waltham, USA). In case of C. parvum mono-infection, medium was changed after 3.5 h and cells were recovered with GM. For infection with G. duodenalis trophozoites solely, IPEC-J2 cells were covered with GM supplemented with 10% modified TYI-S-33. For co-infection, cells were first infected with C. parvum as described, and G. duodenalis trophozoites in GM with 10% modified TYI-S-33 were added to C. parvum infected cells after an incubation time of 3.5 h. In contrast to our former work, in this study only an infection dose of 8 × 105 and 5 × 104 was used for C. parvum sporozoites and G. duodenalis trophozoites, respectively. Infected cells as well as uninfected control cells were harvested after 24 h, 48 h, and 72 h p.i. Monolayer integrity was microscopically checked carefully before harvesting the cells.
The infection was performed five times (n = 5) in case of harvesting after 48 h (n = 5), or six times regarding the harvest after 24 h and 72 h (n = 6).
To determine changes in gene expression of GLUT1, GLUT2, CLDN1, CLDN4, CLDN6, and CLDN7, two wells of a 24-well plate each were pooled and total RNA was extracted using the ReliaPrep™ RNA Cell Miniprep System (Promega GmbH, Mannheim Germany) according to the manufacturer’s instructions including DNAse treatment. One µg of the resulting high-quality RNA was then used to synthesize cDNA using the GoScript® Reverse Transcription System (Promega GmbH, Mannheim Germany) and perform a qPCR reaction with the GoTaq DNA Polymerase kit (Promega GmbH, Mannheim Germany) and the primers as detailed in Table 1 and described previously [10]. Ribosomal protein L4 (RPL4) and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWAHZ) were used as reference genes after confirming their stability using RefFinder and the analysis was performed with the ΔΔCt method [25].
Table 1.
Primers for qPCR
| Gene | GenBank accession number | Amplicon size (bp) | Sequence (5′–3′) |
|---|---|---|---|
| Ribosomal protein L4 (RPL4) | XM_005659862.3 | 92 | F: GCACCACGCAAGAAGATTCA |
| R: TGTCTTTGCATACGGGTTTAGC | |||
| Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWAHZ) | NM_001315726.1 | 87 | F: GGCCCTTAACTTCTCTGTGTT |
| R: GGCTTCATCAAATGCTGTCT | |||
| Glucose transporter 1 (GLUT1) | XM_021096908 | 140 | GCTTCCAGTATGTGGAGCAAC |
| GGAAGCCGGAAGCAATCTCA | |||
| Glucose transporter 2 (GLUT2) | NM_001097447 | 91 | F: TGCTCCAACCAAGTTCAGGG |
| R: AGTCGAGGCCTATGATCTGAC | |||
| Claudin 1 (CLDN1) | NM_001244539.1 | 90 | F: CCCCAGTCAATGCCAGATATGA |
| R: CAAAGTAGGGCACCTCCCAG | |||
| Claudin 4 (CLDN4) | NM_001161637.2 | 148 | F: CGCGACTTCTACAATCCCCT |
| R: GAGTAGGGCTTGTCGGTACG | |||
| Claudin 6 (CLDN6) | NM_001161645.1 | 181 | F: ATCGTCCTGACGCTGTTTGG |
| R: AGCAGCGAGTCATACACCTT | |||
| Claudin 7 (CLDN7) | NM_001160076.1 | 115 | F: TCATCGTGGCAGGTCTTTGT |
| R: GGCAGGGCCAAACTCATACT |
To analyse the intracellular glucose levels of control, single infected and co-infected cells at 48 h p.i., the Glucose-Glo™ Assay (Promega GmbH, Mannheim, Germany) was used as described before [10]. First, the monolayers were checked for integrity microscopically, then placed on ice and washed with ice-cold PBS. Following the manufacturer’s instructions, cells were inactivated first using a 2:1 mixture of PBS and inactivation solution (stock solution: 0.6 N HCl), and neutralized afterwards (stock solution: 1 M Tris; 3:1). After incubation with Glucose Detection Reagent for 1 h, luminescence was recorded using a GloMax® 96 Microplate Luminometer (Promega GmbH, Mannheim, Germany). The experiment was performed four times (n = 4).
Furthermore, immunofluorescent staining for SGLT1 was performed in representative wells of one infection time point each. Therefore, cells were fixed in 4% formaldehyde, preincubated with 4% goat serum and incubated with rabbit-anti-SGLT1 (Bioss Antibodies, #bs-1128R, 1:100) and fluorescently labelled goat-anti-rabbit IgG antibody (Thermo Fisher Scientific, # A-21206, 1:200). In parallel cell nuclei were counterstained with DAPI (Sigma Aldrich, Munich, Germany, 1:5,000) before mounting with glycerol gelatin (Sigma Aldrich, Munich, Germany). The staining was documented using a Leica DM IL LED Fluo IVD microscope and the Leica Application Suite X Software version 3.5.1 using identical settings (exposure time, gain) for each picture.
Graphs were created using GraphPad Prism 11.0 (GraphPad software Inc., San Diego, USA). Statistical analysis was performed using SigmaPlot 14.5 (Systat Software Inc., Erkrath, Germany). A Shapiro–Wilk test was performed to check for normality of the data. Statistical differences between two or more groups were tested using repeated measures one-way analysis of variance (ANOVA) with a subsequent Holm–Sidak test as appropriate. We performed several independent experiments for each analysis, which were considered as repeated measurements and analysed separately for each time point. Statistically significant differences were assumed at p < 0.05.
Results
The mRNA expression of GLUT1 was not significantly altered between the infection groups and control cells at any time point p.i. (Fig. 1A). In contrast, the mRNA expression of GLUT2 was significantly decreased in cells infected by C. parvum compared to cells infected with G. duodenalis (one-way RM ANOVA with post hoc Holm–Sidak test, p = 0.017) and compared to uninfected control cells (one-way RM ANOVA with post hoc Holm–Sidak test, p = 0.021) at 48 h p.i. (Fig. 1B). The same trend was visible at 24 h and 72 h p.i. (one-way RM ANOVA with post hoc Holm–Sidak test, p = 0.062). The mRNA expression level of CLDN1, CLDN4, CLDN6, and CLDN7 was not significantly altered by mono- or co-infection, but a trend towards a downregulation of CLDN1 (one-way RM ANOVA with post hoc Holm–Sidak test, p = 0.073) and CLDN7 (one-way RM ANOVA with post hoc Holm–Sidak test, p = 0.084) in infected cells was observed 48 h and 24 h p.i., respectively (Fig. 1C–F).
Fig. 1.
mRNA expression of glucose transporters and tight junction genes of control cells, mono-infected cells and co-infected cells at 24 h, 48 h, and 72 h p.i.: A GLUT1, B GLUT2, C CLDN1, D CLDN4, E CLDN6, F CLDN7. The boxes show median and 25th/75th percentiles, whiskers show minimum and maximum values of the data set, dots represent replicates of independent experiments; n = 5 (48 h), n = 6 (24 h, 72 h); different letters within the graphs (A, B) indicate significant differences between the treatment groups, p < 0.05; one-way RM ANOVA with post hoc Holm–Sidak test
The intracellular glucose level in co-infected cells was significantly increased compared to control cells (one-way RM ANOVA with post hoc Holm–Sidak test, p = 0.022) and showed a tendency toward an increase compared to G. duodenalis solely infected cells (one-way RM ANOVA with post hoc Holm–Sidak test, p = 0.057) (Fig. 2). Furthermore, C. parvum mono-infected cells showed a non-significant trend towards an increased intracellular glucose level compared to control cells (one-way RM ANOVA with post hoc Holm–Sidak test, p = 0.056) (Fig. 2).
Fig. 2.

Intracellular glucose level in control cells, mono-infected cells and co-infected cells at 48 h p.i. detected with a luminescent assay; the boxes show median and 25th/75th percentiles, whiskers show minimum and maximum values of the data set, dots represent replicates of independent experiments; n = 4; different letters (A, B) indicate significant differences between control and co-infection group, p < 0.05; one-way RM ANOVA with post hoc Holm–Sidak test
SGLT1 expression levels were too low to be detected on mRNA level, but immunofluorescent staining of the protein revealed a positive staining in the cell membranes, with a tendency of the membrane signal to increase in the C. parvum mono-infection compared to the other experimental groups (Additional file 1).
Discussion
Based on our previous finding of enhanced proliferation of G. duodenalis in the co-infection model with C. parvum, we hypothesized that the co-infection has additive effects enhancing the uptake of glucose into infected cells benefitting both parasites [23]. However, the results of this study clearly show a main effect of C. parvum on glucose uptake mechanisms, confirming previous data regarding the influence of C. parvum infection on glucose uptake into enterocytes [10], but do not support additive effects of the co-infection.
Although GLUT2 was downregulated on mRNA level in our current and previous studies, a dislocation of the protein from the membrane was observed in the IPEC-J2 model [10], potentially mirroring a recruitment of the transporter to the apical membrane that could be demonstrated in vivo [17]. Therefore, the mRNA expression may be opposed to the activity of the transporter, possibly in the course of a beginning counterregulation. With GLUT2 mediating the uptake of glucose along a concentration gradient, which can be assumed to exist in the cell culture model using a high glucose cultivation medium, this explains the increased intracellular glucose concentrations that were measured in both C. parvum and co-infected cells and underline the findings on mRNA level that mono-infection with G. duodenalis has no effect on glucose transporter expression also on the functional level.
In our previous studies we additionally found increased gene expression levels and functionality of SGLT1 in C. parvum infected enterocytes as well [10, 17]. The immunofluorescent stainings performed in this study hint on an enhanced signal for SGLT1 in the membrane of C. parvum infected cells, but again no effects of G. duodenalis or co-infection were observed, emphasizing the specific effect of C. parvum on glucose transport. This difference in protein localization was not visible in our previous study using the same cell line and might be due to modifications of the protocol regarding the use of different parasites stages for infection, precisely oocysts versus sporozoites. Furthermore, the cells may have been less differentiated due to a different passage compared to the previous study. This could also be a reason why, in contrast to former studies, we failed to detect SGLT1 on mRNA level.
Yu and colleagues [19] demonstrated an increase of SGLT1-mediated glucose uptake and SGLT1 expression in Caco-2 cells exposed to G. duodenalis sonicates for 24 h in the presence of high glucose media. The authors concluded that the enhanced glucose uptake may represent a defence mechanism against parasite-induced cell apoptosis. In contrast, examining G. lamblia infection in human duodenum from patients with chronic giardiasis, Troeger et al. [26] showed a reduced activity of SGLT1. Those differences may be linked to different infection models, time points and infection doses examined in several studies among other things. Additionally, the infection dose used in our study did not alter cell viability [23] and might therefore not interfere with cell metabolism or initiate cell apoptosis.
Interestingly, co-infection showed no influence on C. parvum growth in vitro, while G. duodenalis replication was significantly increased in presence of C. parvum [23]. In the light of our recent findings it could be hypothesized that a beneficial effect of the increased intracellular glucose levels (mediated by C. parvum) on the viability and replication of G. duodenalis exists. Yet there may be other factors benefitting Giardia trophozoites which might explain the increased parasite replication in presence of C. parvum that need to be elucidated in future studies. Giardia trophozoites preferably use the amino acid arginine instead of glucose for ATP generation and were shown to reduce host cells’ proliferation, induce a halt in cell cycle and strain-dependently also apoptosis [18, 27, 28]. On the other hand, it was hypothesized that C. parvum is also able to modulate cell apoptosis for its own benefit [29], so one may speculate that the modulation of host cell viability and integrity during co-infection could be related to an enhanced Giardia proliferation.
The epithelial integrity and thus resistance to parasitic infection is determined by the barrier forming tight junction proteins. A disruption of several tight junction proteins by C. parvum infection has been shown before and might also be linked to the enhanced replication of G. duodenalis in the co-infection model. However, we could only find small trends for a decreased mRNA expression of CLDN1 and CLDN7 in infected cells.
Consistent with our findings, in Caco-2 cells no changes in mRNA levels were detectable regarding the tight junction protein CLDN4 despite protein levels were decreased after C. parvum infection [7]. In contrast, both mRNA and protein levels of CLDN4 were significantly decreased in C57BL/6 mice infected with C. parvum [7]. These differences may be explained by limited replication of C. parvum in simpler in vitro models compared to organoids or in vivo models. Also, in Caco-2 cells, Kraft et al. [30] examined tight junction proteins including CLDN1 by immunofluorescence assay after Giardia infection and found no significant changes compared to control cells. Based on the outcome, the authors concluded that current in vitro models mirror more likely asymptomatic host–parasite interactions than infections with clinical signs. Regarding giardiasis, Maia-Brigagão et al. [31] could not show changes in the quantity of tight and adherens junctional proteins, but an altered localization of these proteins was observed by immunofluorescence in Giardia-infected Caco-2 cells. Contrary to this, Ma’ayeh et al. [8] showed an upregulation of CLDN4 gene expression in Caco-2 cells after exposure to G. duodenalis assemblage B for 1.5 h, 3 h, and 4.5 h. Additionally, the authors also investigated host cells’ transcriptome showing potential effects on tight junctions’ biogenesis and integrity [8]. Furthermore, Troeger et al. [26] showed a downregulation of CLDN1 in the duodenum of patients with chronic giardiasis. Nevertheless, comparing different studies with varying protocols is difficult and may explain differences in individual study outcomes.
Conclusion
In conclusion, we used an in vitro co-infection model to examine effects on glucose transport and tight junction proteins by the parasites C. parvum and G. duodenalis. While influence on intracellular glucose levels and GLUT2 by single infection with C. parvum was replicable and comparable to the co-infection, G. duodenalis mono-infection showed no effect in regard to the examined parameters. Thus, one may hypothesize that G. duodenalis might benefit from the C. parvum mediated intracellular increase in glucose supply in co-infections. Nevertheless, a range of other factors could be responsible for enhanced Giardia proliferation and more studies are needed. Quantitative analysis of protein levels was not performed in this study, so further investigations could extend the data collected. The infection doses used in this study were selected, because cell viability was not affected while an enhanced replication of G. duodenalis in co-infection compared to control cells was detectable in our previous study [23]. Therefore, the use of higher infection doses and a more complex model, e.g., bovine-derived intestinal organoids as described in previous studies [32], may improve the reflection of clinical disease and associated cellular processes in host cells in a more realistic way and may alleviate limitations such as the restricted life cycle of C. parvum in cell culture.
Supplementary Information
Acknowledgements
The authors thank Adriana Schulz for excellent technical assistance and Uwe Müller for his great support. They are also grateful to the Institute of Veterinary Physiology, Leipzig University, for granting access to the GloMax® 96 Microplate Luminometer (Promega GmbH, Mannheim, Germany).
Author contributions
C.D.: conceptualization, data collection and analysis, visualization, writing—original draft. M.K.: data collection, writing—review and editing. K.M.: writing—review and editing, supervision. F.D.: conceptualization, data collection and analysis, visualization, writing—original draft, supervision. All authors read and approved the final manuscript.
Funding
Open Access funding enabled and organized by Projekt DEAL. This study was supported by the Open Access Publishing Fund of Leipzig University.
Data availability
All data are provided within the manuscript.
Declarations
Ethics approval and consent to participate
All applicable international, national, and/or institutional guidelines for the care and use of the animals were followed. All procedures concerning the animals used for the passage of C. parvum were performed according to the ethical standards of the institution (Regional Council of Saxony following German law: TierSchG, TieSchVersV; permit number; TV vG 06/23).
Consent for publication
All authors agreed to the publication of the manuscript.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382:209–22. [DOI] [PubMed] [Google Scholar]
- 2.Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, et al. MAL-EDNetworkInvestigators. Pathogen– specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health. 2015;3:e564–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Shoultz DA, de Hostos EL, Choy RK. Addressing Cryptosporidium infection among young children in low-income settings: the crucial role of new and existing drugs for reducing morbidity and mortality. PLoS Negl Trop Dis. 2016;10:e0004242. 10.1371/journal.pntd.0004242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Heyworth MF. Giardia duodenalis genetic assemblages and hosts. Parasite. 2016;23:13. 10.1051/parasite/2016013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Cacciò SM, Lalle M, Svärd SG. Host specificity in the Giardia duodenalis species complex. Infect Genet Evol. 2018;66:335–45. 10.1016/j.meegid.2017.12.001. [DOI] [PubMed] [Google Scholar]
- 6.Blikslager A, Gonzalez L. Equine Intestinal Mucosal Pathobiology. Annu Rev Anim Biosci. 2018;6:157–75. 10.1146/annurev-animal-030117-014748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kumar A, Chatterjee I, Anbazhagan AN, Jayawardena D, Priyamvada S, Alrefai WA, et al. Cryptosporidium parvum disrupts intestinal epithelial barrier function via altering expression of key tight junction and adherens junction proteins. Cell Microbiol. 2018;20:e12830. 10.1111/cmi.12830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ma’ayeh SY, Knörr L, Sköld K, Garnham A, Ansell BRE, Jex AR, et al. Responses of the differentiated intestinal epithelial cell line caco-2 to infection with the Giardia intestinalis GS isolate. Front Cell Infect Microbiol. 2018;8:244. 10.3389/fcimb.2018.00244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Edreira MM, Francia ME, de Miguel N. Editorial: host/parasite molecular and cellular interactions in the establishment and maintenance of protozoan infections. Front Cell Infect Microbiol. 2022;12:930073. 10.3389/fcimb.2022.930073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Delling C, Daugschies A, Bangoura B, Dengler F. Cryptosporidium parvum alters glucose transport mechanisms in infected enterocytes. Parasitol Res. 2019;118:3429–41. 10.1007/s00436-019-06471-y. [DOI] [PubMed] [Google Scholar]
- 11.Lendner M, Daugschies A. Cryptosporidium infections: molecular advances. Parasitology. 2014;141:1511–32. 10.1017/S0031182014000237. [DOI] [PubMed] [Google Scholar]
- 12.Wright EM, Martín MG, Turk E. Intestinal absorption in health and disease–sugars. Best Pract Res Clin Gastroenterol. 2003;17:943–56. [DOI] [PubMed] [Google Scholar]
- 13.Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr. 2008;28:35–54. 10.1146/annurev.nutr.28.061807.155518. [DOI] [PubMed] [Google Scholar]
- 14.Chen L, Tuo B, Dong H. Regulation of intestinal glucose absorption by ion channels and transporters. Nutrients. 2016. 10.3390/nu8010043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bürzle M, Hediger MA. Functional and physiological role of vitamin C transporters. Curr Top Membr. 2012;70:357–75. 10.1016/B978-0-12-394316-3.00011-9. [DOI] [PubMed] [Google Scholar]
- 16.Xu R, Beatty WL, Greigert V, Witola WH, Sibley LD. Multiple pathways for glucose phosphate transport and utilization support growth of Cryptosporidium parvum. Nat Commun. 2024;15:380. 10.1038/s41467-024-44696-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Dengler F, Hammon HM, Liermann W, Görs S, Bachmann L, Helm C, et al. Cryptosporidium parvum competes with the intestinal epithelial cells for glucose and impairs systemic glucose supply in neonatal calves. Vet Res. 2023;54:40. 10.1186/s13567-023-01172-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Stadelmann B, Merino MC, Persson L, Svärd SG. Arginine consumption by the intestinal parasite Giardia intestinalis reduces proliferation of intestinal epithelial cells. PLoS ONE. 2012;7:e45325. 10.1371/journal.pone.0045325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Yu LC, Huang CY, Kuo WT, Sayer H, Turner JR, Buret AG. SGLT-1-mediated glucose uptake protects human intestinal epithelial cells against Giardia duodenalis-induced apoptosis. Int J Parasitol. 2008;38:923–34. 10.1016/j.ijpara.2007.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Urie NJ, Lombard JE, Shivley CB, Adams AE, Kopral CA, Santin M. Preweaned heifer management on US dairy operations: part Factors associated with Cryptosporidium and Giardia in preweaned dairy heifer calves. J Dairy Sci. 2018;101(10):9199–213. 10.3168/jds.2017-14060. [DOI] [PubMed] [Google Scholar]
- 21.Murnik LC, Daugschies A, Delling C. Gastrointestinal parasites in young dogs and risk factors associated with infection. Parasitol Res. 2023;12:585–96. 10.1007/s00436-022-07760-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mateusa M, Cīrulis A, Selezņova M, Šveisberga DP, Terentjeva M, Deksne G. Cryptosporidium spp. Are Ass Giardia duodenalis Co-Infect Wild Domestic Canids Animal (Basel). 2024;14:3484. 10.3390/ani14233484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kirchner M, Daugschies A, Delling C. Establishment of an in vitro co-infection model of Cryptosporidium parvum and Giardia duodenalis. Parasit Vectors. 2025;18:281. 10.1186/s13071-025-06926-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Veshkini A, Kühn C, Dengler F, Bachmann L, Liermann W, Helm C, et al. Cryptosporidium parvum infection alters the intestinal mucosa transcriptome in neonatal calves: impacts on epithelial barriers and transcellular transport systems. Front Cell Infect Microbiol. 2024;14:1495309. 10.3389/fcimb.2024.1495309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Xie F, Xiao P, Chen D, Xu L, Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol. 2012;80:75–84. [DOI] [PubMed] [Google Scholar]
- 26.Troeger H, Epple HJ, Schneider T, Wahnschaffe U, Ullrich R, Burchard GD, et al. Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut. 2007;56:328–35. 10.1136/gut.2006.100198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Klotz C, Leisering R, Hagen KD, Starcevich HN, Müller A, Ewald C, et al. Arginine metabolism has a pivotal function for the encystation of Giardia duodenalis. PLoS Pathog. 2026;22:e1013851. 10.1371/journal.ppat.1013851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Solaymani-Mohammadi S. Mucosal Defense Against Giardia at the Intestinal Epithelial Cell Interface. Front Immunol. 2022;13:817468. 10.3389/fimmu.2022.817468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wallbank BA, Pardy RD, Brodsky IE, Hunter CA, Striepen B. Cryptosporidium impacts epithelial turnover and is resistant to induced death of the host cell. MBio. 2024;15:e01720-e1724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kraft MR, Klotz C, Bücker R, Schulzke JD, Aebischer T. Giardia’s Epithelial cell interaction in Vitro: mimicking asymptomatic infection? Front Cell Infect Microbiol. 2017;7:421. 10.3389/fcimb.2017.00421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Maia-Brigagão C, Morgado-Díaz JA, De Souza W. Giardia disrupts the arrangement of tight, adherens and desmosomal junction proteins of intestinal cells. Parasitol Int. 2012;61:280–7. 10.1016/j.parint.2011.11.002. [DOI] [PubMed] [Google Scholar]
- 32.Dykstra GD, Kawasaki M, Burbick CR, McConnel CS, Ambrosini YM. From in vitro development to accessible luminal interface of neonatal bovine-derived intestinal organoids. BMC Vet Res. 2025;1:319. 10.1186/s12917-025-04773-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Müller, U. (2026). Graphical Abstract. Created in BioRender. https://BioRender.com/4admhdu
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data are provided within the manuscript.


